← Back to Search

Behavioral Intervention

Culturally Tailored Recovery Programs for Substance Abuse (IMANI U Trial)

N/A

Recruiting

Led By Chyrell Bellamy, Ph.D.

Research Sponsored by Yale University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Participants must meet criteria for a DSM-5 Alcohol Use Disorder and/or Opioid Use Disorder and are currently using alcohol and/or other opioids within the last 30 days

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12-month

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing ways to get more people of color into medication assisted treatment programs.

Who is the study for?

This trial is for Black or Latinx individuals who want to reduce substance use and have been diagnosed with Alcohol Use Disorder or Opioid Use Disorder, using substances within the last month. They must be interested in treatment and agree to participate by signing a consent form.

What is being tested?

The study is testing culturally tailored recovery programs: IMANI, Telehealth MAT (Medication Assisted Treatment), and traditional MAT with extra support for accessing services. It aims to improve access and engagement in treatment among communities of color.

What are the potential side effects?

While specific side effects are not detailed here, typical side effects from Medication Assisted Treatments can include nausea, headaches, dizziness, fatigue, mood swings, and potential withdrawal symptoms depending on the medication used.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with an alcohol or opioid use disorder and have used these substances in the last 30 days.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12-month

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12-month

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12-month for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Overall attendance of program

Overall treatment adherence

Secondary study objectives

Change in substance abuse

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: IMANI BREAKTROUGH + church-based telehealth MAT option (IMANI + CTM)Experimental Treatment2 Interventions

Participants will participate in the 24-week Imani weekly group. During weeks 1-4 participants will received education on MAT. Those participants randomized will receive the IMANI weekly group as well as a church based telehealth Medication Assisted Treatment option. The church based telehealth MAT will consist of participants assigned to receive MAT from addiction treatment providers via telehealth. Telehealth sessions will be provided in the church.

Group II: IMANI BREAKTHROUGH + Traditional MAT plus Referral and LinkageExperimental Treatment2 Interventions

Participants will participate in the 24-week Imani weekly group. During weeks 1-4 participants will received education on MAT. Those participants randomized will receive the IMANI weekly group as well as Traditional MAT services with Referral and Linkage to services. Participants in this arm will be provided a list of referrals and links to community MAT providers. They will choose their providers.

Group III: IMANI BREAKTHROUGHActive Control1 Intervention

Participants will participate in 24-week IMANI weekly groups

0 / 1Eligibility criteria met